ザーフェル・ギュルバシュ教授は、アナドル医療センターにおける骨髄移植センターの創設者であり、リンパ腫領域における第一線の専門医である。
Dr. Bülent Karagöz は、腫瘍生物学、免疫学、および分子標的療法を専門とする、33年の経験 以上の経験を持つトルコのトップ腫瘍内科医です。
, India
Dr. K.K. Iswaran is a reputed and experienced Obstetrician and Gynaecologist with more than 25 years of experience in his field. His key takeaways include:
Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. She specializes in bone marrow and umbilical blood transplantation for pediatric patients. Dr. El Hasid has conducted over 300 successful transplantations. This volume of procedures provides her with deep clinical insight into complex hematologic cases.
The doctor treats children with blood disorders and various forms of pediatric cancer. She uses high-precision procedures and therapies to improve patient outcomes. Her clinical focus includes:
Dr. El Hasid treats a wide range of hematologic and oncologic conditions, including:
Dr. El Hasid leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. This facility is part of the Sourasky Medical Center (Ichilov) in Tel Aviv. She gained international experience through practice at the City of Hope Hospital in Los Angeles. Additionally, she serves at various medical centers across Israel.
The doctor contributes to the medical community through research and speaking engagements. Her academic record includes:
She stays connected to clinical advancements through several professional organizations:
ロン・ラム医師は、内科、血液学、医療腫瘍学の認定医です。彼のプロフェッショナルな旅は、ニューヨーク州立大学ブルックリン校でのレジデンシーと、ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップを含みます。医学分野への彼の献身は、30以上の科学論文と医学教科書の1章を含む広範な学術的貢献を通じて示されています。さらに、彼は数百件の幹細胞移植を行い、この分野での彼の専門性を強調しています。
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Education:
2015
Dokuz Eylül University, Medical Faculty, Internal Medicine and Hematology
2010
Dokuz Eylül University, Medical Faculty, Internal Medicine
2005
Hacettepe University, Medical Faculty,
Experience:
2024 –
Istanbul Florence Nightingale Hospital
2017 – 2024
Bağcılar Medipol University Hospital
2017 – 2017
Fırat University
2015 - 2017
Fırat University
2014 - 2015
Mayo Clinic
Publications:
18 Articles Published in International Peer-Reviewed Journals
26 Abstracts and Books Presented at International Scientific Conferences
7 Articles Published in National Peer-Reviewed Journals
51 Abstracts Presented at National Scientific Conferences
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.
Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.
Experience
Professional Memberships
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
Children's Hematologist. Specialist in bone marrow transplantation
グラウペラ博士は受賞歴のある小児腫瘍医であり、骨および軟部組織肉腫の名医の一人です。 サンジョアン・デ・デウ病院の血液腫瘍科を率いており、同病院はヨーロッパ屈指の子供病院です。 研究者。 米国で訓練を受けました。
神経芽細胞腫、神経膠腫、ユーイング肉腫、ウィルムス腫瘍の治療を提供します。
ジャウメ・モラ・グラウペラ博士は、子供の悪性腫瘍治療に関する70以上の論文を執筆しています。 放射線療法を用いない脊髄神経膠腫に対する受動的治療法を開発しました。
カンソイ教授はトルコ初の小児骨髄移植ユニットを設立し、国家幹細胞登録機関を統括しています。同教授の研究は白血病治療の標準化に大きく貢献してきました。
イェシム・イルドゥルム教授は、がん免疫療法および分子標的療法を専門とし、80を超える国際学術論文の発表と主要な腫瘍学ハンドブックの共著を有しています。
Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.
He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.
He received his Doctor of Medicine degree from the University of Barcelona in 2002.
Dr. Kobo continues his research and has been awarded grants:
•Interdepartmental Commission for Innovation of the Generalitat de Catalunya
•Scholarship Fund Universitaria Agustí Pedro i Pons
•Farreras Valentí & Schering Plough School of Hematology Scholarship
•Award for the best report at the Council of the Spanish Hematology Association
•Grant from the Catalan Society of Hematology
Specialization:
•Lymphoma
•Acute leukemia
•Chronic leukemia
•Autoimmune pancytopenia
この医師は、小児血液学においてほぼ50年にわたり専念しており、骨髄移植と小児の血液疾患および癌の管理に焦点を当てています。ヨーロッパにおける骨髄移植研究への貢献で認められ、この分野に関連する複雑な手術を専門としています。
この医師は、Children's Cancer Society、European Association for Bone Marrow Transplantation、Turkish and American Society of Hematologyなどの様々な権威ある組織に所属しており、医療コミュニティにおいて重要な存在を確立しています。
1996年に教授の称号を取得し、イスタンブール大学で医学の学位を取得した後、Tsukurov Faculty of Medicineで小児の健康と病気に関する専門的な訓練を修了しました。
Medical Experience:
- 2024 - Present: Memorial Şişli Hospital
Specialist in Internal Medicine and Hematology / Istanbul
- 2017 - 2024: Istanbul Florence Nightingale Hospital
Specialist in Internal Medicine and Hematology / Istanbul
- 2015 - 2017: Eskişehir Yunus Emre State Hospital
Hematology Specialist - Compulsory Service / Eskişehir
Medical Education:
- 2020 - 2024: Istanbul Florence Nightingale Hospital
Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey
- 2017 - 2020: Istanbul Florence Nightingale Hospital
Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey
- 2011 - 2015: Eskişehir Osmangazi University, Faculty of Medicine, Department of Hematology / Eskişehir, Turkey
- 2009 - 2011: Harvard University, Faculty of Medicine / Boston, USA
- 2000 - 2008: Ankara University, Faculty of Medicine / Ankara, Turkey
- 1994 - 2000: Ankara University, Faculty of Medicine / Ankara, Turkey
Attended Professional Trainings, Courses, and Conferences:
- European Society for Blood and Marrow Transplantation, 3rd EBMT International Transplant Course, Barcelona, Course, 07.09.2018-09.09.2018 (International)
- Turkish Academy of Blood Science, Lymphoma Masterclass, Istanbul, Course, 01.09.2016-01.03.2017 (National)
- Advanced Life Support Course, Istanbul
Membership in Professional Associations:
- European Society for Blood and Marrow Transplantation
- Turkish Academy of Blood Science
- Advanced Life Support Course
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 49年の経験 | 骨髄移植 | アナドル骨髄移植センターの創設者。世界有数のがんセンターでの研鑽を積み、トルコを代表する血液腫瘍専門医として高く評価されている。 | トルコ | から $280 | |
| #2 | 33年の経験 | 白血病免疫療法 | 白血病に対する腫瘍免疫学および分子標的療法を専門とする。イスタンブール・オカン大学教授であり、がん研究に関する40本以上の論文を発表している。 | トルコ | から $215 | |
| #3 | 48年の経験 | 小児骨髄移植 | トルコ初の小児移植ユニットを設立し、幹細胞療法の国内権威。小児白血病に関する18本以上の研究論文を持つEBMT理事会メンバー。 | トルコ | お問い合わせください | |
| #4 | 22年の経験 | 免疫療法および分子標的療法 | 最先端のがん免疫療法を専門とし、ESMO認定を取得。『進行がん治療ハンドブック』の共著者。ハリチ大学教授。 | トルコ | から $215 |